Ken Griffin Assembly Biosciences, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.65 - $1.25 $8,872 - $17,062	-13,650 Reduced 9.85%	124,914 $102,000
Q3 2023 Nov 14, 2023	BUY	$0.87 - $1.13 $39,076 - $50,755	44,916 Added 47.96%	138,564 $123,000
Q2 2023 Aug 14, 2023	SELL	$0.81 - $1.15 $38,317 - $54,400	-47,305 Reduced 33.56%	93,648 $107,000
Q1 2023 May 15, 2023	BUY	$0.8 - $1.74 $25,760 - $56,028	32,200 Added 29.61%	140,953 $118,000
Q4 2022 Feb 14, 2023	BUY	$1.09 - $1.52 $88,694 - $123,683	81,371 Added 297.17%	108,753 $141,000

Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.34 $237,292 - $326,626	-139,584 Reduced 83.6%	27,382 $45,000
Q2 2022 Aug 15, 2022	BUY	$1.35 - $2.29 $197,695 - $335,349	146,441 Added 713.48%	166,966 $351,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $7,438 - $12,482	-5,095 Reduced 19.89%	20,525 $42,000
Q4 2021 Feb 14, 2022	SELL	$2.13 - $3.46 $1.75 Million - $2.84 Million	-820,704 Reduced 96.97%	25,620 $59,000
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $105,607 - $131,168	33,633 Added 4.14%	846,324 $2.95 Million
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $274,914 - $329,897	-72,346 Reduced 8.17%	812,691 $3.15 Million
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $378,190 - $579,077	87,342 Added 10.95%	885,037 $4.07 Million
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $1.52 Million - $5.41 Million	-312,776 Reduced 28.17%	797,695 $4.83 Million
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $767,541 - $1.38 Million	-50,898 Reduced 4.38%	1,110,471 $18.3 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $552,479 - $908,539	37,919 Added 3.38%	1,161,369 $27.1 Million
Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $1.2 Million - $2.48 Million	117,023 Added 11.63%	1,123,450 $16.7 Million
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $4.53 Million - $12.9 Million	541,910 Added 116.66%	1,006,427 $20.6 Million
Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $139,605 - $210,473	14,202 Added 3.15%	464,517 $4.57 Million
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $2.95 Million - $4.76 Million	228,963 Added 103.44%	450,315 $6.08 Million
Q1 2019 May 15, 2019	BUY	$17.7 - $24.93 $2.2 Million - $3.09 Million	124,059 Added 127.51%	221,352 $0
Q4 2018 Feb 14, 2019	BUY	$19.05 - $36.45 $1.45 Million - $2.77 Million	76,035 Added 357.68%	97,293 $2.2 Million
Q2 2018 Aug 10, 2018	BUY	$39.21 - $50.29 $339,989 - $436,064	8,671 Added 68.89%	21,258 $0
Q4 2017 Feb 09, 2018	BUY	$28.58 - $49.91 $359,736 - $628,217	12,587	12,587 $569,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$223,841
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account